On a model-based approach to improve intranasal spray targeting for respiratory viral infections
Frontiers in Drug Delivery · 30.05.2023 · 3
DOI: 10.3389/fddev.2023.1164671 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Drug Delivery, online erschienen am 30.05.2023. Verfasst von Mohammad Mehedi Hasan Akash und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Mechanical Engineering, South Dakota State University, Brookings, SD, United States. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Foundation.
Abstract (Originalsprache)
The nasopharynx, at the back of the nose, constitutes the dominant initial viral infection trigger zone along the upper respiratory tract. However, as per the standard recommended usage protocol (“Current Use”, or CU) for intranasal sprays, the nozzle should enter the nose almost vertically, resulting in sub-optimal nasopharyngeal drug deposition. Through the Large Eddy Simulation technique, this study has replicated airflow under standard breathing conditions with 15 and 30 L/min inhalation rates, passing through medical scan-based anatomically accurate human airway cavities. The small-scale airflow fluctuations were resolved through use of a sub-grid scale Kinetic Energy Transport Model. Intranasally sprayed droplet trajectories for different spray axis placement and orientation conditions were subsequently tracked via Lagrangian-based inert discrete phase simulations against the ambient inhaled airflow field. Finally, this study verified the computational projections for the upper airway drug deposition trends against representative physical experiments on sprayed delivery performed in a 3D-printed anatomic replica. The model-based exercise has revealed a new “Improved Use” (or, IU) spray usage protocol for viral infections. It entails pointing the spray bottle at a shallower angle (with an almost horizontal placement at the nostril), aiming slightly toward the cheeks. From the conically injected spray droplet simulations, we have summarily derived the following inferences: (a) droplets sized between 7–17 μ m are relatively more efficient at directly reaching the nasopharynx via inhaled transport; and (b) with realistic droplet size distributions, as found in current over-the-counter spray products, the targeted drug delivery through the IU protocol outperforms CU by a remarkable 2 orders-of-magnitude.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Mechanical Engineering, South Dakota State University, Brookings, SD, United States.
- Department of Biomedical Engineering, Boston University, Boston, MA, United States.
- Joint Department of Biomedical Engineering, University of North Carolina-North Carolina State University, Chapel Hill, NC, United States.
- Aptar Pharma, Congers, NY, United States.
- Fractal Therapeutics, Cambridge, MA, United States.
- Bioengineering Technology and Entrepreneurship Center, Boston University, Boston, MA, United States.
Förderung
- National Science Foundation
Zitieren
APA
Akash, M. M. H., Lao, Y., Balivada, P. A., Ato, P., Ka, N. K., Mituniewicz, A., Silfen, Z., Suman, J. D., Chakravarty, A., Joseph-McCarthy, D., & Basu, S. (2023). On a model-based approach to improve intranasal spray targeting for respiratory viral infections. Frontiers in Drug Delivery, 3. https://doi.org/10.3389/fddev.2023.1164671
Vancouver
Akash MMH, Lao Y, Balivada PA, Ato P, Ka NK, Mituniewicz A, et al. On a model-based approach to improve intranasal spray targeting for respiratory viral infections. Frontiers in Drug Delivery. 2023;3. doi:10.3389/fddev.2023.1164671
BibTeX
@article{Akash2023,
author = {Akash, Mohammad Mehedi Hasan and Lao, Yueying and Balivada, Pallavi A and Ato, Phoebe and Ka, Nogaye K and Mituniewicz, Austin and Silfen, Zachary and Suman, Julie D and Chakravarty, Arijit and Joseph-McCarthy, Diane and Basu, Saikat},
title = {On a model-based approach to improve intranasal spray targeting for respiratory viral infections},
journal = {Frontiers in Drug Delivery},
year = {2023},
volume = {3},
doi = {10.3389/fddev.2023.1164671}
}
EUVIMED